# Commission Implementing Regulation (EU) 2015/152 of 30 January 2015 amending the Annex to Regulation (EU) No 37/2010, as regards the substance ‘tulathromycin’ (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tulathromycin’ is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic classification
‘Tulathromycin
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents
Ovine, caprine
450 μg/kg
Muscle
Not for use in animals from which milk is produced for human consumption
Anti-infectious agents/Antibiotics’
250 μg/kg
Fat
5 400 μg/kg
Liver
1 800 μg/kg
Kidney
Bovine
300 μg/kg
Muscle
Not for use in animals from which milk is produced for human consumption
Provisional MRLs expire on 1 January 2015
200 μg/kg
Fat
4 500 μg/kg
Liver
3 000 μg/kg
Kidney
Porcine
800 μg/kg
Muscle
Provisional MRLs expire on 1 January 2015
300 μg/kg
Skin and fat in natural proportions
4 000 μg/kg
Liver
8 000 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2015/152/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2015-152/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.